Comments
Guggul, Brahmi, Aswagandha, Amla, Gokshur…These are a few of the hundreds of herbal extracts that are now driving the fortunes of the nutraceutical industry.
Right proportionThese extracts, used in the right proportions, help in a range of benefits that include strengthening one’s memory or improving one’s general health.
They contain anti-oxidants, have anti-inflammatory properties as well as boost the fortification of probiotics and vitamins. Taking advantage of these properties, Satyavathi BioLife Sciences Ltd has set up a manufacturing-cum-quality certification facility in Nandigama in Krishna district of Andhra Pradesh.
“We are the first company to go into production at the place which has been declared as one of the pharmaceutical/nutraceutical clusters in AP by the Chief Minister, N Chandrababu Naidu. So far ₹25 crore has been invested in the facility”, said Naveen Srinivasa, the young Chief Executive Officer.
Satyavathi BioLife makes bulk extracts of 15 herbs.
All these have been certified by AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy) Department.
The totally export oriented unit is scouting for clients, predominantly in the US and then in Europe, Srinivasa told BusinessLine .
Ready for formulation“We have talked to 20-25 firms which are into vitamins and probiotics. Our capability is to manufacture to the specifications of the customers, who will use the extracts to formulate their products for the market.
Our extracts are ready for formulation into energy drinks, food supplements, capsules and vitamin supplement products,” he added.
The company does not require the approval of the US Food and Drug Administration as it supplies only herbal extracts (which are like Active Pharmaceutical Ingredients), but need to go through stringent quality certification, for which the necessary instruments and facilities have been established in Nandigama, which is an hour’s drive from Vijayawada and Amaravati, the new capital region of AP.
According to the Pharmexil, the export of nutraceuticals from India was around ₹10,000 crore last year.
The nutraceuticals market is fast growing and the company is exploring the scope for setting up a research centre to scale up the value chain in making new products and formulations in the future, Srinivasa said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.